This revised application requests renewal of the Baylor-UT Houston Center for AIDS Research (CFAR), formerly the Baylor CFAR. This reflects the new partnership of Baylor with The University of Texas Health Science Center at Houston (UT Houston), both located in the Texas Medical Center in Houston. Both institutions strongly endorse this partnership, and in the year since the previous application, the Baylor and UTHouston components of the CFAR have been successfully integrated. The partnership broadens the HIV/AIDS research programs and opportunities for translational research in the CFAR by adding UT Houston programs in adult HIV/AIDS clinical studies and in the behavioral sciences to Baylor's existing strengths. Our combined NIH Funded Research Base for FY2003 totals $21.9 million. We used a comprehensive strategic planning process to address reviewer comments. We obtained advice from NIH CFAR program officials and our External Advisors and conducted a thorough revaluation of each CFAR core. This resulted in major reorganizations and modifications in the goals, functions, and/or services provided by the Clinical Research, Behavioral Science, and International Research Cores. Other scientific cores (Immunology, Virology, Design and Analysis) are also revised. Cores are now more innovative and focused on CFAR goals. New approaches were designed to use Developmental Core funds in novel ways to foster translational research. Strategies include targeting research activities that fill gaps, take advantage of opportunities in the CFAR, and encourage interactions between institutions and synergy among CFAR Cores. A Scientific Program will be supported in HIV and Coinfections, focusing on HIV and Mycobacterium tuberculosis, areas of expertise at our CFAR. Several of these new research programs utilize the infrastructure at Baylor's international sites in Romania and Botswana. We believe these changes result in a more visionary, proactive CFAR. A comprehensive mentoring program for junior faculty in HIV/AIDS research is new to this reapplication. The CFAR is led by Janet S. Butel, Ph.D. (Director), William T. Shearer, M.D., Ph.D. (Co-Director), and Richard M. Grimes, Ph.D. (Associate Director and Liaison to UTHouston). CFAR decisions and actions are guided by a set of Policies and Procedures and an annual Strategic Planning Process. The major policy-making body of the CFAR is the Internal Advisory Committee; management is assisted by External Advisory and Developmental Grants Scientific Review Committees.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036211-12
Application #
7094219
Study Section
Special Emphasis Panel (ZAI1-LW-A (J1))
Program Officer
Young, Janet M
Project Start
1997-04-01
Project End
2010-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
12
Fiscal Year
2006
Total Cost
$1,500,497
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Misra, Anisha; Gleeson, Emile; Wang, Weiming et al. (2018) Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity. J Virol 92:
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Nabekura, Tsukasa; Chen, Zhiying; Schroeder, Casey et al. (2018) Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection. J Immunol 200:3420-3428
Haller, Meade; Au, Jason; O'Neill, Marisol et al. (2018) 16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A 115:E1849-E1858
Tan, Qiumin; Brunetti, Lorenzo; Rousseaux, Maxime W C et al. (2018) Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma. Proc Natl Acad Sci U S A 115:E1511-E1519
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055
Bui, Thanh Cong; Scheurer, Michael E; Pham, Vy Thi-Tuong et al. (2018) Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia. J Med Virol 90:1765-1774
Kim, Myunghoo; Galan, Carolina; Hill, Andrea A et al. (2018) Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity 49:151-163.e5
Martini-Stoica, Heidi; Cole, Allysa L; Swartzlander, Daniel B et al. (2018) TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med 215:2355-2377
Kogiso, Mari; Qi, Lin; Braun, Frank K et al. (2018) Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Clin Cancer Res 24:2159-2170

Showing the most recent 10 out of 690 publications